Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-235710
Filing Date
2009-11-16
Accepted
2009-11-16 16:03:18
Documents
7
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 910572
2 SECOND AMENDED AND RESTATED BYLAWS OF THE REGISTRANT dex32.htm EX-3.2 68753
3 LEASE SURRENDER AND TERMINATION AGREEMENT dex101.htm EX-10.1 22696
4 CODE OF BUSINESS CONDUCT AND ETHICS dex141.htm EX-14.1 85849
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 5970
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 5872
7 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 5610
  Complete submission text file 0001193125-09-235710.txt   1106936
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 091186763
SIC: 2835 In Vitro & In Vivo Diagnostic Substances